Target intelligence / Profile preview

Immune cell membranes and local tissue environment

Molecular classification
Other
01

Overview

The immune cell membranes and local tissue environment represent a complex biological compartment rather than a single molecular target (Nature Reviews Cancer, 2021). This environment includes the lipid bilayers of various immune cells, such as T cells and macrophages, as well as the surrounding extracellular matrix (ECM), signaling molecules, and metabolic conditions like pH and oxygen levels (Journal of Cell Science, 2019). In many diseases, particularly cancer, this environment is altered to create an immunosuppressive niche that prevents effective immune clearance (NIH, National Cancer Institute). The local tissue environment, often referred to as the tumor microenvironment (TME) in oncology, acts as a physical and biochemical barrier to therapy. Therapeutic interventions often focus on modulating this environment—either by blocking inhibitory receptors on the cell membranes or by altering the physical and chemical properties of the local tissue—to restore normal immune function and improve drug penetration (PubMed, PMC6753017). For example, checkpoint inhibitors target proteins on the immune cell membrane to re-activate T cells within this milieu. Additionally, enzymes like hyaluronidase are used to degrade components of the local tissue environment to facilitate the spread of co-injected drugs. Understanding the interplay between the cellular membrane and the surrounding environment is crucial for developing next-generation immunotherapies and delivery systems.

Other names
Tumor microenvironmentTMECellular milieuExtracellular matrixImmune synapsePericellular space
02

Mechanism of action

Modulation of the local immune milieu through receptor-ligand blockade on cell membranes or enzymatic degradation of extracellular matrix components to enhance immune infiltration and drug delivery.

03

Biological functions

Immune responseCell signalingCell-cell interactionHomeostasisMetabolic regulation
04

Disease associations

CancerInflammationAutoimmune diseaseInfectionFibrosis
05

Safety considerations

Cytokine release syndrome (CRS)Immune-related adverse events (irAEs)Systemic inflammatory responseTissue fibrosis
06

Interacting drugs

3 more in the full profile.

07

Biomarkers

Tumor-infiltrating lymphocytes (TILs)Programmed death-ligand 1 (PD-L1) expressionLactate concentrationHypoxia-inducible factor 1-alpha (HIF-1α)

Beyond the preview

Go deeper on Immune cell membranes and local tissue environment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune cell membranes and local tissue environment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call